JP2006514110A5 - - Google Patents

Download PDF

Info

Publication number
JP2006514110A5
JP2006514110A5 JP2005506646A JP2005506646A JP2006514110A5 JP 2006514110 A5 JP2006514110 A5 JP 2006514110A5 JP 2005506646 A JP2005506646 A JP 2005506646A JP 2005506646 A JP2005506646 A JP 2005506646A JP 2006514110 A5 JP2006514110 A5 JP 2006514110A5
Authority
JP
Japan
Prior art keywords
phenyl
substituted
alkyl
alkoxy
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2005506646A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006514110A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2003/011976 external-priority patent/WO2004043926A1/en
Publication of JP2006514110A publication Critical patent/JP2006514110A/ja
Publication of JP2006514110A5 publication Critical patent/JP2006514110A5/ja
Pending legal-status Critical Current

Links

JP2005506646A 2002-11-11 2003-10-29 Ip受容体アンタゴニストとしてのフェニルまたはヘテロアリールアミノアルカン誘導体 Pending JP2006514110A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02025024 2002-11-11
EP03011397 2003-05-20
PCT/EP2003/011976 WO2004043926A1 (en) 2002-11-11 2003-10-29 Phenyl or heteroaryl amino alkane derivatives as ip receptor antagonist

Publications (2)

Publication Number Publication Date
JP2006514110A JP2006514110A (ja) 2006-04-27
JP2006514110A5 true JP2006514110A5 (https=) 2006-12-07

Family

ID=32313830

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2005506646A Pending JP2006514110A (ja) 2002-11-11 2003-10-29 Ip受容体アンタゴニストとしてのフェニルまたはヘテロアリールアミノアルカン誘導体

Country Status (19)

Country Link
US (1) US20060089371A1 (https=)
EP (1) EP1575919A1 (https=)
JP (1) JP2006514110A (https=)
KR (1) KR20050074571A (https=)
AR (1) AR042023A1 (https=)
AU (1) AU2003276201A1 (https=)
BR (1) BR0316191A (https=)
CA (1) CA2505361A1 (https=)
CO (1) CO5580824A2 (https=)
EC (1) ECSP055789A (https=)
HN (1) HN2003000353A (https=)
HR (1) HRP20050529A2 (https=)
MA (1) MA27491A1 (https=)
NO (1) NO20052797D0 (https=)
PE (1) PE20040672A1 (https=)
PL (1) PL376993A1 (https=)
TW (1) TW200418799A (https=)
UY (1) UY28072A1 (https=)
WO (1) WO2004043926A1 (https=)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60120104T2 (de) 2001-03-20 2006-09-21 Schwarz Pharma Ag Neue Verwendung von Peptidverbindungen bei der Behandlung von nicht-neuropathischem Entzündungsschmerz
DK1243263T3 (da) 2001-03-21 2003-03-17 Sanol Arznei Schwarz Gmbh Hidtil ukendt anvendelse af en klasse af peptidforbindelser til behandling af allodyni eller andre forskellige typer af kronisk- eller fantomsmerte
JP4664924B2 (ja) 2003-12-02 2011-04-06 ウーツェーベー ファルマ ゲーエムベーハー 中枢神経因性疼痛の治療のためのペプチド化合物の新規使用
CA2545422C (en) 2003-12-03 2015-06-02 Cytopia Research Pty Ltd Tubulin inhibitors
EP1604655A1 (en) 2004-06-09 2005-12-14 Schwarz Pharma Ag Novel use of peptide compounds for treating pain in trigeminal neuralgia
EA014055B1 (ru) 2004-08-27 2010-08-30 Шварц Фарма Аг Применение пептидных соединений для лечения боли при раке кости, а также боли, вызванной химиотерапией и нуклеозидами
WO2006029735A1 (en) * 2004-09-15 2006-03-23 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with prostaglandin 12 receptor (ptgir)
HN2005000795A (es) * 2004-10-15 2010-08-19 Aventis Pharma Inc Pirimidinas como antagonistas del receptor de prostaglandina d2
PE20070404A1 (es) 2005-07-29 2007-05-10 Wyeth Corp Compuestos derivados de cianopirrol-sulfonamida como moduladores del receptor de progesterona
PE20070341A1 (es) * 2005-07-29 2007-04-13 Wyeth Corp Derivados de pirrol como moduladores del receptor de progesterona
PE20070182A1 (es) 2005-07-29 2007-03-06 Wyeth Corp Derivados cianopirrol-fenil amida como moduladores del receptor de progesterona
CN101258142A (zh) 2005-08-02 2008-09-03 莱西肯医药有限公司 作为蛋白激酶抑制剂的2-氨基芳基吡啶
EA019757B1 (ru) 2006-06-15 2014-06-30 ЮСиБи ФАРМА ГМБХ Фармацевтическая композиция с синергетическим противосудорожным эффектом
US20080242694A1 (en) * 2006-09-18 2008-10-02 D Sidocky Neil R Amino-substituted heterocycles, compositions thereof, and methods of treatment therewith
JO3598B1 (ar) * 2006-10-10 2020-07-05 Infinity Discovery Inc الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني
WO2009132310A1 (en) * 2008-04-25 2009-10-29 Wisconsin Alumni Research Foundation Inhibitors of udp-galactopyranose mutase thwart mycobacterial growth
US20100060985A1 (en) 2008-09-09 2010-03-11 Fujifilm Corporation Method for producing polarizing plate, and automobile's windshield
US8536185B2 (en) 2008-09-22 2013-09-17 Cayman Chemical Company, Incorporated Multiheteroaryl compounds as inhibitors of H-PGDS and their use for treating prostaglandin D2 mediated diseases
US9133123B2 (en) 2010-04-23 2015-09-15 Cytokinetics, Inc. Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
AR081626A1 (es) 2010-04-23 2012-10-10 Cytokinetics Inc Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos
AR081331A1 (es) 2010-04-23 2012-08-08 Cytokinetics Inc Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
US8759380B2 (en) 2011-04-22 2014-06-24 Cytokinetics, Inc. Certain heterocycles, compositions thereof, and methods for their use
WO2014134391A1 (en) 2013-02-28 2014-09-04 Bristol-Myers Squibb Company Phenylpyrazole derivatives as potent rock1 and rock2 inhibitors
AR094929A1 (es) 2013-02-28 2015-09-09 Bristol Myers Squibb Co Derivados de fenilpirazol como inhibidores potentes de rock1 y rock2
SG11201509186TA (en) 2013-06-27 2016-01-28 Pfizer Heteroaromatic compounds and their use as dopamine d1 ligands
US9828393B2 (en) * 2013-07-22 2017-11-28 The Regents Of The University Of Colorado, A Body Corporate Silylalkyloxyaryl compounds and methods for treating cancer
US9994547B2 (en) 2014-10-06 2018-06-12 Takeda Pharmaceutical Company Limited Heteroarylamide inhibitors of TBK1
US10080757B2 (en) 2016-03-11 2018-09-25 Wisconsin Alumni Research Foundation Inhibitors of UDP-galactopyranose mutase

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4259489A (en) * 1977-12-22 1981-03-31 Kyowa Gas Chemical Industry Co. Ltd. 2,3-Dicyanopyrazines
WO1996033972A1 (en) * 1995-04-28 1996-10-31 Glaxo Group Limited Methods for synthesizing diverse collections of pyridines, pyrimidines, 1,4-dihydro derivatives thereof, and piperidine derivatives
EA002100B1 (ru) * 1996-12-23 2001-12-24 Элан Фармасьютикалз, Инк. ЦИКЛОАЛКИЛЬНЫЕ СОЕДИНЕНИЯ, ЛАКТАМЫ, ЛАКТОНЫ И РОДСТВЕННЫЕ СОЕДИНЕНИЯ, СОДЕРЖАЩИЕ ИХ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ И СПОСОБЫ ИНГИБИРОВАНИЯ ВЫСВОБОЖДЕНИЯ И/ИЛИ СИНТЕЗА β-АМИЛОИДНОГО ПЕПТИДА С ПОМОЩЬЮ УКАЗАННЫХ СОЕДИНЕНИЙ
GB2323842A (en) * 1997-04-04 1998-10-07 Ferring Bv Pyridine derivatives
WO2000043372A1 (en) * 1999-01-22 2000-07-27 Elan Pharmaceuticals, Inc. Acyl derivatives which treat vla-4 related disorders
US20020058606A1 (en) * 1999-05-10 2002-05-16 Gonzalez Maria Isabel Treatment of sexual dysfunction
YU68102A (sh) * 2000-03-16 2006-01-16 F. Hoffmann-La Roche Ag. Derivati karboksilne kiseline kao ip antagonisti
DE60113290D1 (de) * 2000-11-17 2005-10-13 Warner Lambert Co Behandlung von sexueller funktionsstörung mit bombesin rezeptor antagonisten
DE60209227T2 (de) * 2001-05-30 2006-08-17 Novartis Ag 2-((n-(2-amino-3-(heteroaryl- oder -aryl)propionyl)aminoacyl)amino)-alkylboronsäurederivate

Similar Documents

Publication Publication Date Title
JP2006514110A5 (https=)
RU2404164C2 (ru) Производные пиридин-3-карбоксамида в качестве обратных агонистов св1
RU2485114C2 (ru) Карбоксамидные соединения и их применение в качестве ингибиторов кальпаинов
RU2436780C2 (ru) Производные 5-фенилтиазола и их применение в качестве ингибиторов рi3 киназы
RU2497822C2 (ru) Селективные к bcl-2 агенты, вызывающие апоптоз, для лечения рака и иммунных заболеваний
RU2451674C2 (ru) Пиридинкарбоксамиды в качестве ингибиторов 11-бета-hsd1
RU2482111C2 (ru) Соединения, обладающие противораковой активностью
JP2007519754A5 (https=)
JP2004521087A5 (https=)
JP2013517283A5 (https=)
RU2006131304A (ru) Производные имидазо[1,2-c]пиримидинилуксусной кислоты
JP2006524645A5 (https=)
JP2005538955A5 (https=)
JP2004517925A5 (https=)
HUP0401950A2 (hu) Pirimidin-származékok és ilyen vegyületeket tartalmazó gyógyászati készítmények
JP2006509748A5 (https=)
RU2007117913A (ru) 2, 6-замещенные-4-монозамещенный амино-пиримидины как антагонисты рецептора простагландина d2
RU2003115612A (ru) Производные амидоалкилпиперидинов и амидоалкилпиперазинов, пригодные для лечения нарушений нервной системы
JP2005533827A5 (https=)
RU2004135064A (ru) Новые замещенные индолы
RU2008117329A (ru) Производные имидазопиридина как антагонисты аденозинового рецептора а2в
RU2010110640A (ru) Соединения и композиции 5-(4-(галогеналкокси)фенил)пиримидин-2-амина в качестве ингибиторов киназ
CA2504907A1 (en) Indoles useful in the treatment of androgen-receptor related diseases
JP2005523901A (ja) Npyアンタゴニストとしてのキノリン誘導体
JP2016540045A5 (https=)